EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Clinicopathologic Features of NRG1 Fusion‐Positive Non‐Small Cell Lung Cancer

Bahadır Köylü iD, Nur İlayda Genç iD, Mehmet Haluk Yücel iD, Anıl Yıldız iD, Esra Aşık iD, Cevat İlteriş Kıkılı iD, Fatih Kemik iD, Nazan Demir iD, Pınar Bulutay iD, Ömer Fatih Ölmez iD, Fatih Selçukbiricik iD

Genes, Chromosomes and Cancer · 2026

DOI: 10.1002/gcc.70170 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Genes, Chromosomes and Cancer, 2026. Verfasst von Bahadır Köylü und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Koç University School of Medicine, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neuregulin-1, Oncogene Proteins, Fusion. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data on the clinicopathological features of NRG1 fusion‐positive non‐small cell lung cancer (NSCLC) are limited. We conducted a retrospective, multicenter study and included patients with NRG1 fusion‐positive NSCLC diagnosed between January 2018 and February 2025. Six patients were identified; five were female (83.3%), two were never‐smokers (33.3%), and four were former smokers (66.7%). Adenocarcinoma was the predominant histology ( n = 5), comprising mucinous ( n = 2), enteric ( n = 2), and not otherwise specified ( n = 1) variants, while one patient had squamous cell carcinoma. All were PD‐L1–negative, and CD74‐NRG1 was the most common fusion (50%). Three patients received afatinib; only one achieved a partial response with a progression‐free survival of 8.7 months. Median overall survival was 6.7 months. Our study demonstrates the histologic and molecular heterogeneity of NRG1 fusion‐positive NSCLC, encompassing mucinous and enteric variants of adenocarcinoma. Responses to afatinib were variable, underscoring the need for more effective therapies, including zenocutuzumab and emerging agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeuregulin-1Oncogene Proteins, FusionAgedFemaleHumansMaleMiddle AgedAfatinibRetrospective Studies

Stichwörter der Autor:innen

Neuregulinafatinibgene fusionlung cancermucinous adenocarcinoma

Substanzen

AfatinibNeuregulin-1NRG1 protein, humanOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Koç University School of Medicine, Istanbul, Türkiye.
  • Department of Internal Medicine, Koç University School of Medicine, Istanbul, Türkiye.
  • Division of Medical Oncology, Department of Internal Medicine, Medipol University School of Medicine, Istanbul, Türkiye.
  • Department of Medical Oncology, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye.
  • Division of Medical Oncology, Department of Internal Medicine, Karadeniz Technical University Faculty of Medicine, Trabzon, Türkiye.
  • Department of Pathology, Koç University School of Medicine, Istanbul, Türkiye.

ORCID-Profile: Bahadır Köylü, Nur İlayda Genç, Mehmet Haluk Yücel, Anıl Yıldız, Esra Aşık, Cevat İlteriş Kıkılı, Fatih Kemik, Nazan Demir, Pınar Bulutay, Ömer Fatih Ölmez, Fatih Selçukbiricik

Zitieren

APA

Köylü, B., Genç, N. İ., Yücel, M. H., Yıldız, A., Aşık, E., Kıkılı, C. İ., Kemik, F., Demir, N., Bulutay, P., Ölmez, Ö. F., & Selçukbiricik, F. (2026). Clinicopathologic Features of NRG1 Fusion‐Positive Non‐Small Cell Lung Cancer. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70170

Vancouver

Köylü B, Genç Nİ, Yücel MH, Yıldız A, Aşık E, Kıkılı Cİ, et al. Clinicopathologic Features of NRG1 Fusion‐Positive Non‐Small Cell Lung Cancer. Genes, Chromosomes and Cancer. 2026. doi:10.1002/gcc.70170

BibTeX
@article{Kyl2026,
  author = {Köylü, Bahadır and Genç, Nur İlayda and Yücel, Mehmet Haluk and Yıldız, Anıl and Aşık, Esra and Kıkılı, Cevat İlteriş and Kemik, Fatih and Demir, Nazan and Bulutay, Pınar and Ölmez, Ömer Fatih and Selçukbiricik, Fatih},
  title = {Clinicopathologic Features of NRG1 Fusion‐Positive Non‐Small Cell Lung Cancer},
  journal = {Genes, Chromosomes and Cancer},
  year = {2026},
  doi = {10.1002/gcc.70170}
}
Kostenlos starten →